Consolidation period of 18 months no better at promoting off-treatment durability in HBeAg-positive chronic hepatitis B patients with tenofovir disoproxil fumarate treatment than a 12-month period: A prospective randomized cohort study

There has been no clear consensus on the optimal consolidation periods following HBeAg seroconversion (SC) in HBeAg-positive chronic hepatitis B (CHB) patients. Our study aimed to prospectively compare relapse rates between 12 months’ and 18 months’ consolidation periods to see whether or not there...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chun-Hsiang, Chang, Kuo-Kuan, Lin, Ruey-Chang, Kuo, Ming-Jeng, Yang, Chi-Chieh, Tseng, Yuan-Tsung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440314/
https://www.ncbi.nlm.nih.gov/pubmed/32358357
http://dx.doi.org/10.1097/MD.0000000000019907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440314/
https://www.ncbi.nlm.nih.gov/pubmed/32358357
http://dx.doi.org/10.1097/MD.0000000000019907

Ejemplares similares